Stocks
Funds
Screener
Sectors
Watchlists

Latest Parkman Healthcare Partners LLC Stock Portfolio

Parkman Healthcare Partners LLC Performance:
2025 Q2: -0.61%YTD: -3.6%2024: 10.77%

Performance for 2025 Q2 is -0.61%, and YTD is -3.6%, and 2024 is 10.77%.

About Parkman Healthcare Partners LLC and 13F Hedge Fund Stock Holdings

Parkman Healthcare Partners LLC is a hedge fund based in STAMFORD, CT. On 27-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $591.9 Millions. In it's latest 13F Holdings report, Parkman Healthcare Partners LLC reported an equity portfolio of $870.1 Millions as of 30 Jun, 2025.

The top stock holdings of Parkman Healthcare Partners LLC are CVS, PODD, BSX. The fund has invested 4.1% of it's portfolio in CVS HEALTH CORP and 3.8% of portfolio in INSULET CORP.

The fund managers got completely rid off BECTON DICKINSON & CO (BDX), UNITEDHEALTH GROUP INC (UNH) and RESMED INC (RMD) stocks. They significantly reduced their stock positions in UROGEN PHARMA LTD (URGN), DAY ONE BIOPHARMACEUTICALS I (DAWN) and PRECIGEN INC (PGEN). Parkman Healthcare Partners LLC opened new stock positions in IQVIA HLDGS INC (IQV), GENEDX HOLDINGS CORP (SMFR) and ASCENDIS PHARMA A/S. The fund showed a lot of confidence in some stocks as they added substantially to MERUS N V (MRUS), UPSTREAM BIO INC and ARCELLX INC (ACLX).

Parkman Healthcare Partners LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Parkman Healthcare Partners LLC made a return of -0.61% in the last quarter. In trailing 12 months, it's portfolio return was 2.07%.

New Buys

Ticker$ Bought
iqvia hldgs inc17,256,100
genedx holdings corp16,154,200
ascendis pharma a/s7,267,840
certara inc5,850,000
waystar hldg corp5,721,800
incyte corp5,107,500
amylyx pharmaceuticals inc4,166,500
quanterix corp3,431,350

New stocks bought by Parkman Healthcare Partners LLC

Additions

Ticker% Inc.
merus n v477
upstream bio inc206
mbx biosciences inc165
arcellx inc158
outset med inc137
uniqure nv117
quidelortho corp110
danaher corporation74.06

Additions to existing portfolio by Parkman Healthcare Partners LLC

Reductions

Ticker% Reduced
urogen pharma ltd-55.06
day one biopharmaceuticals i-52.07
precigen inc-51.66
ultragenyx pharmaceutical in-51.36
arcus biosciences inc-50.67
gilead sciences inc-39.86
kiniksa pharmaceuticals intl-35.91
cvrx inc-35.82

Parkman Healthcare Partners LLC reduced stake in above stock

Sold off

Ticker$ Sold
icad inc-1,610,240
maravai lifesciences hldgs i-1,458,600
silence therapeutics plc-1,132,920
vyne therapeutics inc-344,405
keros therapeutics inc-2,218,900
ironwood pharmaceuticals inc-301,476
oric pharmaceuticals inc-1,132,770
relay therapeutics inc-492,696

Parkman Healthcare Partners LLC got rid off the above stocks

Sector Distribution

Parkman Healthcare Partners LLC has about 86.9% of it's holdings in Healthcare sector.

Sector%
Healthcare86.9
Others10.7
1.9

Market Cap. Distribution

Parkman Healthcare Partners LLC has about 47.3% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
LARGE-CAP44.3
SMALL-CAP24.5
MID-CAP12.8
UNALLOCATED10.7
MICRO-CAP4.3
MEGA-CAP3

Stocks belong to which Index?

About 67.7% of the stocks held by Parkman Healthcare Partners LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
S&P 50036.2
Others32.3
RUSSELL 200031.5
Top 5 Winners (%)%
OPRX
optimizerx corp
50.5 %
VRNA
verona pharma plc
49.0 %
TERN
terns pharmaceuticals inc
35.1 %
THC
tenet healthcare corp
30.9 %
PFMT
performant healthcare inc
29.4 %
Top 5 Winners ($)$
THC
tenet healthcare corp
8.9 M
VRNA
verona pharma plc
8.1 M
PODD
insulet corp
6.7 M
ALNY
alnylam pharmaceuticals inc
3.9 M
NBIX
neurocrine biosciences inc
2.5 M
Top 5 Losers (%)%
LUNG
pulmonx corp
-61.5 %
CVRX
cvrx inc
-51.9 %
RXST
rxsight inc
-48.4 %
AXGN
axogen inc
-35.9 %
EWTX
edgewise therapeutics inc
-30.8 %
Top 5 Losers ($)$
CVRX
cvrx inc
-7.8 M
RXST
rxsight inc
-7.7 M
ZBH
zimmer biomet holdings inc
-4.4 M
BMRN
biomarin pharmaceutical inc
-4.4 M
COO
cooper cos inc
-4.1 M

Parkman Healthcare Partners LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Parkman Healthcare Partners LLC

Parkman Healthcare Partners LLC has 87 stocks in it's portfolio. About 32.2% of the portfolio is in top 10 stocks. CVRX proved to be the most loss making stock for the portfolio. THC was the most profitable stock for Parkman Healthcare Partners LLC last quarter.

Last Reported on: 14 Aug, 2025
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions